Miromatrix Biological Mesh for Hiatal Hernia Repair

Completed · Not applicable

Conditions studied: Hiatal Hernia

In brief

Miromatrix Medical has developed MIROMESH® - a new, noncrosslinked, acellular mesh derived from the highly vascularized porcine liver. MIROMESH received FDA 510(k) clearance with an indication for reinforcement of soft tissue on March 31, 2014 under K134033. This study will serve to provide clinicians with high-quality clinical data in order to provide them with a higher degree of confidence when selecting MIROMESH for hiatal hernia repair.

Key facts

Study ID

NCT02436681

Run by

Miromatrix Medical Inc.

People needed

50

Starts

2015-08-01

Expected to finish

2018-07-01

Last updated by the study team

2019-09-20

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• between 18 and 80 years old on the day of study enrollment
• able and willing to sign the consent form and comply with all study visits and procedures
• able to undergo elective laparoscopic hiatal hernia repair
• free of cognitive or speech impairment
• documented, symptomatic type II or III hernia ≥5cm in the axial/vertical dimension
• commit to non-smoking for at least 4 weeks prior to procedure

You may not qualify if…

• previous operation of the esophagus or stomach
• sensitivity to porcine material
• pregnant or plan to be pregnant within next 2 years
• immunocompromised or at risk of immunosuppression (i.e. be HIV positive, be experiencing organ rejection, be a recent or anticipated chemotherapy recipient) as determined by the Investigator
• require emergent operation for acute gastric volvulus or strangulation
• American Society of Anesthesiology (ASA) class 4 or greater
• BMI ≥40
• life expectancy of less than 2 years at the time of enrollment
• associated gastrointestinal disease that requires extensive medical or surgical intervention that might interfere with the quality of life assessment (e.g. Crohn's disease)
• any condition in the opinion of the Investigator that would preclude the use of the study device, or preclude the subject from completing the follow-up requirements

Where it is running

• University of Kentucky — Lexington, Kentucky, United States
• Monmouth Medical Center — Long Branch, New Jersey, United States
• Carolinas Healthcare System — Charlotte, North Carolina, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Virginia Heartburn and Hernia Institute — Lorton, Virginia, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.